4.4 |
13.1 |
GO:0060244 |
negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
2.1 |
8.5 |
GO:2000054 |
negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
2.0 |
6.1 |
GO:0050929 |
corticospinal neuron axon guidance through spinal cord(GO:0021972) positive regulation of negative chemotaxis(GO:0050924) induction of negative chemotaxis(GO:0050929) negative regulation of mononuclear cell migration(GO:0071676) negative regulation of retinal ganglion cell axon guidance(GO:0090260) |
1.9 |
15.4 |
GO:0048625 |
myoblast fate commitment(GO:0048625) |
1.6 |
11.3 |
GO:0072257 |
metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
1.5 |
4.5 |
GO:1904059 |
regulation of locomotor rhythm(GO:1904059) |
1.3 |
4.0 |
GO:0046022 |
regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
1.2 |
3.7 |
GO:0003221 |
right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
1.2 |
6.1 |
GO:0035262 |
gonad morphogenesis(GO:0035262) |
1.1 |
5.7 |
GO:0031022 |
nuclear migration along microfilament(GO:0031022) |
1.1 |
3.3 |
GO:0032696 |
negative regulation of interleukin-13 production(GO:0032696) odontoblast differentiation(GO:0071895) regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
1.0 |
3.9 |
GO:2000705 |
regulation of dense core granule biogenesis(GO:2000705) |
0.9 |
3.8 |
GO:0021764 |
amygdala development(GO:0021764) |
0.9 |
6.3 |
GO:0000022 |
mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
0.9 |
4.3 |
GO:0061086 |
negative regulation of histone H3-K27 methylation(GO:0061086) |
0.9 |
6.1 |
GO:0000320 |
re-entry into mitotic cell cycle(GO:0000320) |
0.8 |
4.2 |
GO:0046684 |
response to pyrethroid(GO:0046684) |
0.8 |
3.3 |
GO:0046552 |
eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
0.8 |
2.3 |
GO:0021893 |
cerebral cortex GABAergic interneuron fate commitment(GO:0021893) |
0.7 |
2.2 |
GO:0048818 |
positive regulation of hair follicle maturation(GO:0048818) positive regulation of catagen(GO:0051795) regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
0.7 |
2.2 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
0.7 |
2.1 |
GO:0090258 |
negative regulation of mitochondrial fission(GO:0090258) |
0.7 |
2.8 |
GO:0007056 |
spindle assembly involved in female meiosis(GO:0007056) |
0.7 |
4.1 |
GO:0097368 |
establishment of Sertoli cell barrier(GO:0097368) |
0.7 |
10.9 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.6 |
1.9 |
GO:2000314 |
negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
0.6 |
1.8 |
GO:2000686 |
regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.6 |
3.0 |
GO:0060838 |
lymphatic endothelial cell fate commitment(GO:0060838) regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
0.6 |
2.9 |
GO:1900122 |
positive regulation of receptor binding(GO:1900122) |
0.6 |
2.3 |
GO:0060836 |
lymphatic endothelial cell differentiation(GO:0060836) |
0.6 |
2.8 |
GO:0010792 |
DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.5 |
1.1 |
GO:0007406 |
negative regulation of neuroblast proliferation(GO:0007406) |
0.5 |
1.6 |
GO:0017085 |
response to insecticide(GO:0017085) |
0.5 |
6.0 |
GO:2000741 |
positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.5 |
1.6 |
GO:0060023 |
soft palate development(GO:0060023) |
0.5 |
2.1 |
GO:2000795 |
negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
0.5 |
2.1 |
GO:0001550 |
ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
0.5 |
2.6 |
GO:0046501 |
protoporphyrinogen IX metabolic process(GO:0046501) |
0.5 |
3.5 |
GO:0071699 |
olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.5 |
8.8 |
GO:0021860 |
pyramidal neuron development(GO:0021860) |
0.5 |
2.4 |
GO:0010835 |
regulation of protein ADP-ribosylation(GO:0010835) N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.5 |
1.4 |
GO:0044337 |
canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
0.5 |
5.1 |
GO:0060539 |
diaphragm development(GO:0060539) |
0.5 |
1.4 |
GO:0048211 |
Golgi vesicle docking(GO:0048211) |
0.5 |
5.4 |
GO:0048853 |
forebrain morphogenesis(GO:0048853) |
0.4 |
3.1 |
GO:0007296 |
vitellogenesis(GO:0007296) |
0.4 |
1.3 |
GO:0060743 |
epithelial cell maturation involved in prostate gland development(GO:0060743) alveolar secondary septum development(GO:0061144) |
0.4 |
1.6 |
GO:0002572 |
pro-T cell differentiation(GO:0002572) |
0.4 |
1.6 |
GO:0035616 |
histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.4 |
0.4 |
GO:0036515 |
serotonergic neuron axon guidance(GO:0036515) |
0.4 |
3.4 |
GO:2000794 |
positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000794) |
0.4 |
2.3 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
0.4 |
3.7 |
GO:1902231 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.4 |
7.9 |
GO:0001967 |
suckling behavior(GO:0001967) |
0.4 |
1.8 |
GO:0031133 |
cellular magnesium ion homeostasis(GO:0010961) regulation of axon diameter(GO:0031133) |
0.3 |
1.7 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
0.3 |
5.9 |
GO:0036342 |
post-anal tail morphogenesis(GO:0036342) |
0.3 |
2.6 |
GO:0035881 |
amacrine cell differentiation(GO:0035881) |
0.3 |
7.4 |
GO:0007617 |
mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.3 |
2.8 |
GO:0071420 |
cellular response to histamine(GO:0071420) |
0.3 |
2.1 |
GO:0060028 |
convergent extension involved in axis elongation(GO:0060028) |
0.3 |
0.9 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
0.3 |
1.1 |
GO:1904565 |
response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
0.3 |
3.6 |
GO:0070102 |
interleukin-6-mediated signaling pathway(GO:0070102) |
0.3 |
7.2 |
GO:0001573 |
ganglioside metabolic process(GO:0001573) |
0.3 |
2.7 |
GO:0070933 |
histone H4 deacetylation(GO:0070933) |
0.3 |
1.3 |
GO:2000325 |
nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.3 |
4.8 |
GO:0021521 |
ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.3 |
2.0 |
GO:0010815 |
bradykinin catabolic process(GO:0010815) |
0.2 |
1.7 |
GO:0033184 |
positive regulation of histone ubiquitination(GO:0033184) |
0.2 |
3.3 |
GO:0060712 |
spongiotrophoblast layer development(GO:0060712) |
0.2 |
3.6 |
GO:0060218 |
hematopoietic stem cell differentiation(GO:0060218) |
0.2 |
1.1 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
0.2 |
2.2 |
GO:0051574 |
positive regulation of histone H3-K9 methylation(GO:0051574) |
0.2 |
4.2 |
GO:0010763 |
positive regulation of fibroblast migration(GO:0010763) |
0.2 |
0.7 |
GO:2000297 |
negative regulation of synapse maturation(GO:2000297) |
0.2 |
0.6 |
GO:0048388 |
endosomal lumen acidification(GO:0048388) synaptic vesicle lumen acidification(GO:0097401) |
0.2 |
1.7 |
GO:0014842 |
regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
0.2 |
7.8 |
GO:0048384 |
retinoic acid receptor signaling pathway(GO:0048384) |
0.2 |
3.1 |
GO:0030903 |
notochord development(GO:0030903) |
0.2 |
5.2 |
GO:0009409 |
response to cold(GO:0009409) |
0.2 |
1.2 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
0.2 |
0.9 |
GO:0090148 |
protein hexamerization(GO:0034214) membrane fission(GO:0090148) |
0.2 |
3.1 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
0.2 |
3.1 |
GO:1902043 |
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.2 |
7.0 |
GO:0002053 |
positive regulation of mesenchymal cell proliferation(GO:0002053) |
0.2 |
5.4 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.2 |
1.3 |
GO:0090074 |
negative regulation of protein homodimerization activity(GO:0090074) |
0.2 |
0.2 |
GO:0042421 |
norepinephrine biosynthetic process(GO:0042421) |
0.2 |
0.5 |
GO:1905154 |
negative regulation of tumor necrosis factor secretion(GO:1904468) negative regulation of membrane invagination(GO:1905154) |
0.2 |
1.6 |
GO:0033148 |
positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.2 |
1.2 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
0.1 |
5.5 |
GO:2001222 |
regulation of neuron migration(GO:2001222) |
0.1 |
1.3 |
GO:0035280 |
miRNA mediated inhibition of translation(GO:0035278) miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.1 |
0.4 |
GO:0072497 |
mesenchymal stem cell differentiation(GO:0072497) |
0.1 |
1.3 |
GO:0035414 |
negative regulation of catenin import into nucleus(GO:0035414) |
0.1 |
0.8 |
GO:0061687 |
detoxification of inorganic compound(GO:0061687) |
0.1 |
1.0 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
0.1 |
1.5 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
0.1 |
1.5 |
GO:0070914 |
UV-damage excision repair(GO:0070914) |
0.1 |
3.1 |
GO:0035329 |
hippo signaling(GO:0035329) |
0.1 |
1.4 |
GO:0043252 |
sodium-independent organic anion transport(GO:0043252) |
0.1 |
1.6 |
GO:0043162 |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 |
0.8 |
GO:0035988 |
chondrocyte proliferation(GO:0035988) |
0.1 |
0.4 |
GO:0072697 |
protein localization to cell cortex(GO:0072697) |
0.1 |
0.3 |
GO:0090327 |
negative regulation of locomotion involved in locomotory behavior(GO:0090327) |
0.1 |
0.3 |
GO:0019405 |
alditol catabolic process(GO:0019405) glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
0.1 |
1.0 |
GO:0043928 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.1 |
2.7 |
GO:0010842 |
retina layer formation(GO:0010842) |
0.1 |
1.2 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.1 |
0.8 |
GO:0036371 |
protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
0.1 |
0.6 |
GO:0042756 |
positive regulation of heat generation(GO:0031652) drinking behavior(GO:0042756) |
0.1 |
1.3 |
GO:0006337 |
nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.1 |
0.8 |
GO:0048681 |
negative regulation of axon regeneration(GO:0048681) |
0.1 |
0.4 |
GO:0033088 |
negative regulation of immature T cell proliferation(GO:0033087) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.1 |
0.4 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
0.1 |
1.9 |
GO:0006301 |
postreplication repair(GO:0006301) |
0.1 |
2.0 |
GO:0060074 |
synapse maturation(GO:0060074) |
0.1 |
0.5 |
GO:0034047 |
regulation of protein phosphatase type 2A activity(GO:0034047) |
0.1 |
1.0 |
GO:0051292 |
nuclear pore complex assembly(GO:0051292) |
0.1 |
2.9 |
GO:0060612 |
adipose tissue development(GO:0060612) |
0.1 |
2.6 |
GO:0045600 |
positive regulation of fat cell differentiation(GO:0045600) |
0.1 |
1.2 |
GO:0014912 |
negative regulation of smooth muscle cell migration(GO:0014912) |
0.1 |
0.5 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
0.1 |
1.3 |
GO:0021884 |
forebrain neuron development(GO:0021884) |
0.1 |
0.8 |
GO:0031507 |
heterochromatin assembly(GO:0031507) |
0.1 |
0.9 |
GO:0072600 |
establishment of protein localization to Golgi(GO:0072600) |
0.1 |
0.4 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
0.1 |
0.7 |
GO:0015937 |
coenzyme A biosynthetic process(GO:0015937) |
0.0 |
0.1 |
GO:1904683 |
regulation of metalloendopeptidase activity(GO:1904683) negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
0.0 |
2.1 |
GO:1901998 |
toxin transport(GO:1901998) |
0.0 |
5.2 |
GO:0006338 |
chromatin remodeling(GO:0006338) |
0.0 |
0.8 |
GO:0007289 |
spermatid nucleus differentiation(GO:0007289) |
0.0 |
1.7 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
0.0 |
0.7 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
0.0 |
0.1 |
GO:1902260 |
negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.0 |
0.7 |
GO:0099500 |
synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.0 |
2.4 |
GO:0050852 |
T cell receptor signaling pathway(GO:0050852) |
0.0 |
0.3 |
GO:0007413 |
axonal fasciculation(GO:0007413) |
0.0 |
0.2 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
0.0 |
0.1 |
GO:1901250 |
regulation of lung goblet cell differentiation(GO:1901249) negative regulation of lung goblet cell differentiation(GO:1901250) |
0.0 |
0.8 |
GO:0034637 |
glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) cellular polysaccharide biosynthetic process(GO:0033692) cellular carbohydrate biosynthetic process(GO:0034637) |
0.0 |
0.2 |
GO:1900103 |
positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
0.0 |
0.5 |
GO:0048147 |
negative regulation of fibroblast proliferation(GO:0048147) |
0.0 |
0.2 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.0 |
0.5 |
GO:0097352 |
autophagosome maturation(GO:0097352) |
0.0 |
5.9 |
GO:0007018 |
microtubule-based movement(GO:0007018) |
0.0 |
0.8 |
GO:0002028 |
regulation of sodium ion transport(GO:0002028) |
0.0 |
0.8 |
GO:0006376 |
mRNA splice site selection(GO:0006376) |
0.0 |
0.1 |
GO:0006646 |
phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.0 |
0.2 |
GO:0048642 |
negative regulation of skeletal muscle tissue development(GO:0048642) |
0.0 |
1.3 |
GO:0042147 |
retrograde transport, endosome to Golgi(GO:0042147) |
0.0 |
0.8 |
GO:0060976 |
coronary vasculature development(GO:0060976) |
0.0 |
2.6 |
GO:0042384 |
cilium assembly(GO:0042384) |
0.0 |
1.0 |
GO:1904893 |
negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 |
0.4 |
GO:0072337 |
modified amino acid transport(GO:0072337) |
0.0 |
0.6 |
GO:0045599 |
negative regulation of fat cell differentiation(GO:0045599) |
0.0 |
1.4 |
GO:0030326 |
embryonic limb morphogenesis(GO:0030326) embryonic appendage morphogenesis(GO:0035113) |
0.0 |
0.2 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
0.0 |
0.2 |
GO:0032486 |
Rap protein signal transduction(GO:0032486) |
0.0 |
1.0 |
GO:0045638 |
negative regulation of myeloid cell differentiation(GO:0045638) |
0.0 |
0.2 |
GO:0043552 |
positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.0 |
0.2 |
GO:0048026 |
positive regulation of mRNA splicing, via spliceosome(GO:0048026) |